ISSN: 0026-4725

Journal Home

Journal Guideline

Minerva Cardioangiologica Q3 Unclaimed

Edizioni Minerva Medica S.p.A. Italy

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Minerva Cardioangiologica is a journal indexed in SJR in Cardiology and Cardiovascular Medicine with an H index of 25. It has a best quartile of Q3. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

-

SJR Impact factor

25

H Index

90

Total Docs (Last Year)

249

Total Docs (3 years)

2907

Total Refs

150

Total Cites (3 years)

201

Citable Docs (3 years)

0,73

Cites/Doc (2 years)

323.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Geriatric Cardiology Q3
Cardiovascular Engineering and Technology Q3
Phlebology Q3
Thrombosis Q3
Cardiovascular Revascularization Medicine Q3

Compare this journals

Aims and Scope

Best articles by citations

COLCOT and CANTOS: piecing together the puzzle of inflammation and cardiovascular events

A handbook for the clinical cardiologist about CRT/ICD. A practical guide about how to survive during an on call shift

Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study

The future of percutaneous tricuspid valve interventions

Impella-protected PCI: the clinical results achieved so far

Impella: pumps overview and access site management

Long-term prognostic impact of non-invasive follow-up with computed tomography angiography in patients with left main coronary artery stenting

Definitions and clinical impact of revascularization completeness

Antihypertensive effect of sacubitril/valsartan: a meta-analysis

Pycnogenol¬Æ+Centellicum¬Æ, post-stent evaluation: prevention of neointima and plaque re-growth

Transcatheter therapies for tricuspid regurgitation: coaptation augmentation devices

A simple prognostic index in acute heart failure

SHOW MORE ARTICLES

Use of DOACs in real-world challenging settings: a Delphi Consensus from Italian cardiologists

Could mechanical thrombectomy replace thrombolysis in the treatment of acute and subacute limb ischemia?

Percutaneous tricuspid annuloplasty

Percutaneous tricuspid valve replacement: orthotopic and heterotopic valves

The association of neutrophil to lymphocyte ratio and TIMI frame count in primary percutaneous coronary intervention

"ECG in noonan syndrome: beyond the ""normal abnormalities"

A glimpse into upcoming TAVI era: new is coming

Minerva Cardioangiologica: glancing backward, rushing forward

Deferred stenting for acute myocardial infarction of late admission

"Merging the properties of a sirolimus coated balloon with those of a bioresorbable polymer sirolimus eluting stent to address the ""diabetes issue"". Results from the En-Abl multicenter registry"

Cardiogenic shock due to coronary fistula: a complex phenomenon

Clinical relevance of myocardial bridging detected by coronary CT angiography in patients with atypical chest pain